Todd Carter - Jan 6, 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
Chief Scientific Officer
Signature
/s/ Robert Hesslein, as Attorney-in-Fact for Todd Carter
Stock symbol
VYGR
Transactions as of
Jan 6, 2023
Transactions value $
-$481
Form type
4
Date filed
1/10/2023, 03:07 PM
Previous filing
Sep 21, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Award $2.01K +388 +1.07% $5.17 36.6K Dec 31, 2022 Direct F1
transaction VYGR Common Stock Sale -$2.49K -388 -1.06% $6.41 36.2K Jan 6, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d).